Reviewer Disclosures

ReviewerEmploymentResearch GrantOther Research SupportSpeakers’ Bureau/HonorariaExpert WitnessOwnership InterestConsultant/Advisory BoardOther
Paul BarashYale University Medical CenterNoneNoneNoneNoneNoneNoneNone
Paula GralingInova Fairfax HospitalInova Seed grant (compliance with surgical safety checklist across perioperative services)†NoneNoneNoneNoneAORN (unpaid)*None
Loren HiratzkaBethesda North HospitalNoneNoneNoneNoneNoneNoneNone
Jeffrey RileyMayo Clinic, RochesterNoneNoneNoneNoneNoneNoneNone
Marc RuelUniversity of Ottawa Heart InstituteNoneNoneNoneNoneNoneNoneNone
Doug WiegmannUniversity of Wisconsin–MadisonUS Department of DefenseNoneGrand rounds talk*NoneNoneAmerican College of Surgeons (unpaid)*None
  • This table represents the relationships of reviewers that may be perceived as actual or reasonably perceived conflicts of interest as reported on the Disclosure Questionnaire, which all reviewers are required to complete and submit. A relationship is considered to be “significant” if (1) the person receives $10 000 or more during any 12-month period, or 5% or more of the person’s gross income; or (2) the person owns 5% or more of the voting stock or share of the entity, or owns $10 000 or more of the fair market value of the entity. A relationship is considered to be “modest” if it is less than “significant” under the preceding definition.

  • * Modest.

  • Significant.